相关实验视频
Updated: Jun 18, 2026
11:19
Oral Biofilm Formation on Different Materials for Dental Implants
Published on: June 24, 2018
11.5K
围植入炎治疗成功的预测因素:前性队列研究的协议
Yuanxi Zhu1, Hongye Lu2, Shuo Yang1
1Center of Oral Implantology, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
BMJ open
|January 10, 2024
概括
这项研究确定了在275名患者中预测成功治疗植入周炎的因素. 了解这些预测因素可以改善这种常见的牙科植入物并发症的结果.
科学领域:
- 牙科植入物学 牙科植入物学
- 牙周病学 牙周病学
- 生物材料科学 生物材料科学
背景情况:
- 周植入炎是牙科植入物的普遍并发症,治疗成功有限.
- 现有的研究确定了围植入炎发病的风险因素,但缺乏预测治疗结果的数据.
- 这项研究解决了为成功的周植入炎治疗确定预后因素的需要.
研究的目的:
- 为了确定成功的周植入炎治疗的局部和全身预测因素.
- 提供数据,以改善治疗策略和周植入炎患者管理.
- 为了提高牙科植入物修复的长期成功率.
主要方法:
- 一项前性队列研究,涉及275名被诊断患有围植入炎的患者.
- 数据收集包括社会人口统计学变量,生活方式因素,系统健康以及临床/放射检查.
- 治疗的成功是由特定的临床和放射性标准在12个月的随访,使用多变量逻辑回归分析定义的.
主要成果:
- 分析社会人口统计,生活方式和临床数据,以确定预后因素.
- 确定与成功或不成功的周植入炎治疗结果相关的关键指标.
- 基于已识别的因素进行统计建模,以预测治疗成功.
结论:
- 这项研究将阐明成功治疗植入周炎的关键预测因素.
- 预计这些发现将指导临床决策,并加强患者护理方案.
- 这项研究有助于改善受围植入炎影响的牙植入物的寿命和功能.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...